Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
QBIO Q BIOMED INC
0.0080.0000.00%
Trading Session
01/31 12:01 ET
High
0.008
Open
0.008
Turnover
6.33K
Low
0.008
Pre Close
0.008
Volume
790.56K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Expands By 21.2%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant growth in short interest in the month of December. As of December 30th, there was short interest totalling 189,900 shares,
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Increases By 2,468.9%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 156,700 shares, a gr
Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 23,000 shares, a dro
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Grows By 50.0%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 45,900 shares, an increase of 50.
Traders News Source Senior Editor Mark Roberts Interviews Denis D Corin, CEO and Chairman Q BioMed Inc.
NEW YORK, NY / ACCESSWIRE / August 25, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issue
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Drops By 99.5%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 100 shares, a drop of 99.5% fr
Press Release: Q BioMed Inc. Provides Update to Shareholders
Q BioMed Inc. Provides Update to Shareholders PR Newswire NEW YORK, July 29, 2022 Company Reports Revenue Improvement and Positive Data on Pipeline Assets NEW YORK, July 29, 2022 /PRNewswire/ -- Q
Q BioMed Inc. (OTCMKTS:QBIO) Sees Significant Drop in Short Interest
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 100 shares, a drop o
Q BioMed Outlines Strategy and Value Proposition in Multi-Billion Dollar Markets
Management's assessment and value of Q BioMed outlined NEW YORK, May 6, 2022 /PRNewswire/ -- Q BioMed, Inc. (OTCQB:QBIO) a commercial-stage biotechnology development company outlines its strategy and value proposition for its stakeholders and sharehol
Q BioMed Inc. (OTCMKTS:QBIO) Sees Significant Growth in Short Interest
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 42,600 shares, an increase of 17.0%
Company Overview
More
Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
CEO： --
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet